Value Bridge — NYU LANGONE HOSPITALS
Current $-568M → Target $-408M (+$160.0M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-567.7M
Current EBITDA
$-407.7M
Target EBITDA
+$160.0M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$36.2M
Payer Mix Optimization
$86.9M
Cost to Collect Reduction
$29.0M
Clean Claim Improvement
$21.7M
Volume & Rate Growth
$144.8M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-568M to $-408M. The highest-impact lever is Volume & Rate Growth at $57.9M probability-weighted.
IC talking point: "We see $160M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $1760M in equity value creation."